Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XCF2 | ISIN: US09062W2044 | Ticker-Symbol: BJX1
Tradegate
30.10.24
18:29 Uhr
22,000 Euro
-0,400
-1,79 %
1-Jahres-Chart
BIOLIFE SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
BIOLIFE SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
21,80022,40013:05
22,20022,40001.11.

Aktuelle News zur BIOLIFE SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:15Insider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 547 Shares of Stock1
30.09.H.C. Wainwright unterstützt BioLife Solutions-Aktie und verweist auf Biokonservierungsdienste3
30.09.H.C. Wainwright backs BioLife Solutions stock, cites biopreservation services1
18.09.Biolife Solutions exec sells over $77k in company stock2
18.09.Biolife Solutions exec sells over $17k in company stock1
18.09.Biolife Solutions executive sells over $14k in company stock1
18.09.Biolife Solutions executive sells over $17k in company stock1
18.09.Biolife Solutions CFO sells shares worth over $35k1
18.09.Biolife Solutions CMO sells over $17,000 in company stock1
19.08.BioLife Solutions (BLFS) Surpassed Revenue and Earnings-Per-Share Expectations in Q22
09.08.BioLife Solutions Inc reports results for the quarter ended in June - Earnings Summary1
08.08.BioLife Solutions GAAP EPS of -$0.50 misses by $0.36, revenue of $28.3M beats by $4.35M1
08.08.BioLife Solutions, Inc.: BioLife Solutions Reports Second Quarter 2024 Financial Results123Cell Processing revenue increased 11% sequentially to $18.0 million GAAP gross margin of 51% and non-GAAP adjusted gross margin of 52% GAAP net loss from continuing operations of $7.1 million and...
► Artikel lesen
06.08.BIOLIFE SOLUTIONS INC - 8-K, Current Report-
31.05.BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase2
10.05.BIOLIFE SOLUTIONS INC - 10-Q, Quarterly Report3
10.05.BioLife Solutions Inc reports results for the quarter ended in March - Earnings Summary3
09.05.BioLife Solutions GAAP EPS of -$0.22, revenue of $31.7M2
09.05.BioLife Solutions, Inc.: BioLife Solutions Reports First Quarter 2024 Financial Results222Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands from 40% to 53% and adjusted EBITDA...
► Artikel lesen
29.02.BioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results211Fourth quarter Cell Processing revenue up 11% sequentially to $14.8 million, and positive adjusted EBITDA of $700,000 Expects 2024 revenue of $95.5 - $100.0 million excluding freezer business and...
► Artikel lesen
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1